Active Immunization of Patients With Non Small Cell Lung Cancer (NSCLC) Using Fibroblasts Transfected With DNA From Autologous Tumor (Phase IB Study).

Status: Discontinued

Phase of Trial: Phase I

Latest Information Update: 09 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs IC 1001 (Primary)
Indications Non-small cell lung cancer
Focus Adverse reactions; Pharmacodynamics

Most Recent Events

10 Apr 2019 Status changed from recruiting to discontinued.
16 Aug 2012 Actual initiation date changed from 1 Dec 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
02 Jun 2012 Trial design presented at the 48th Annual Meeting of the American Society of Clinical Oncology.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight